by embracemarketing | Nov 5, 2026 | BLOG
The European Society for Medical Oncology (ESMO) Congress 2026 in Madrid brought together leading oncology professionals, researchers and industry experts from around the world to share the latest research, innovations and developments in cancer treatment and patient...
by embracemarketing | Oct 26, 2026 | BLOG
The European Association for the Study of Diabetes (EASD) 2026 conference in Milan brought together the latest research and developments in diabetes and metabolic health.Here, Ben Walker (Director) shares Adelphi Research’s perspective from the conference. Reflections...
by embracemarketing | Jul 14, 2026 | BLOG
This summer, Adelphi Research conducted a self-funded post-conference survey following the American Diabetes Association (ADA) 2026 conference in New Orleans. We captured agile insights from healthcare professionals on what generated the most excitement, drove...
by embracemarketing | Dec 10, 2025 | BLOG
GLP-1 medications like Ozempic, Wegovy and Mounjaro have moved far beyond the clinic. They’ve become mainstream cultural symbols, appearing in TikTok trends, celebrity conversations and even on Christmas trees. This cultural shift is shaping perceptions of treatment...
by embracemarketing | Dec 17, 2025 | BLOG
We’re closing out 2025 with a year defined by clarity, impact and forward momentum. Across 461 studies, we helped teams transform complexity into clear, actionable insights. We supported 155 brands and assets, translating insight into outcomes that sharpened strategy...
by embracemarketing | Nov 12, 2025 | BLOG
This autumn, Adelphi Research explored two of the biggest healthcare conferences, ESMO 2025 and EASD 2025, capturing agile insights from healthcare professionals and uncovering the key trends shaping oncology and diabetes care. Our post-conference surveys reveal what...
Recent Comments